Foreign Drug Makers In China Eye Third and Fourth Tier Markets
This article was originally published in PharmAsia News
Executive Summary
The Chinese government's price cuts on brand drugs have switched foreign drug makers' attention to the country's third and fourth tier cities and primary healthcare markets